Evaluating the clinical utility of newly blepharo-tensiometer on ocular surface disease.

Evaluating the clinical utility of newly blepharo-tensiometer on ocular surface disease. - Evaluating the clinical utility of newly blepharo-tensiometer.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs062180052

Enrollment

250

Registered

2019-03-14

Start date

2014-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lid-Wiper Epitheliopaty, facial nerve paralysis, oculomotor nerve palsy, hyperthyroidism, ptosis etc

Interventions

Patients of ocular surface disease (ptosis, etc) are measured eyelid pressure by Blepharo-tensiometer.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of ocular surface disease (ptosis, etc.) The eligible subjects were >=20 years and written informed consent.

Exclusion criteria

Exclusion criteria: 1. Active ocular infection 2. Corneal ulcer 3. Allergy of topical anesthesia 4. Pregnant, unwilling to practice contraception during the study,or lactating female

Design outcomes

Primary

Measure	Time frame
eyelid pressure	—

Secondary

Measure	Time frame
adverse events	—

Contacts

Public ContactAtsushi Shiraishi

Ehime university hospital

shiraia@m.ehime-u.ac.jp+81-89-960-5361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026